Hannah Joseph Hospital last traded at ₹101.85 (2026-10-13). Over the past month the stock moved -9.2%, three months the stock moved +41.4%. Its closing range over 52 weeks is ₹56.53 – ₹118.90, with the latest close 14.3% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2011, Hannah Joseph Hospital Limited is a healthcare provider offering exceptional medical services across various specialties.[1]
Business Profile[1] Hannah Joseph Hospital Limited (HJHL) is a 150-bed multi-speciality tertiary care hospital based in Madurai, Tamil Nadu, with a dominant focus on Neurosciences, Cardiac Sciences, Psychiatry and Trauma care.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 50.00 | 13.00 | 27.00 | 6.00 | 2.67 |
| Sep 2025 | 43.00 | 12.00 | 28.00 | 5.00 | 3.07 |
| Mar 2025 | 37.00 | 9.00 | 25.00 | 3.00 | 1.87 |
In the latest year (Mar 2026), Hannah Joseph Hospital reported sales of ₹92.00 crore (+18.7%) and net profit of ₹11.00 crore (+52.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 92.00 | 25.00 | 27.00 | 11.00 | 4.93 |
| Mar 2025 | 77.53 | 20.69 | 26.69 | 7.21 | 4.32 |
| Mar 2024 | 63.41 | 18.14 | 28.61 | 4.07 | 2.44 |
| Mar 2023 | 54.62 | 16.54 | 30.28 | 1.01 | 0.62 |
| Mar 2021 | 35.59 | 7.41 | 20.82 | -2.45 | -13.86 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | +53.5% | +16.1% | +22.3% | +18.7% |
| Operating profit growth | +123.2% | +9.7% | +14.1% | +20.8% |
| Net profit growth | – | +303.0% | +77.1% | +52.6% |
| EPS growth | – | +293.5% | +77.0% | +14.1% |
| OPM % | 30.3% | 28.6% | 26.7% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Hannah Joseph Hospital has rallied 40.9% over 1 year and surged 9.6% today to ₹78.9, trading 11.2% below its 52W high of ₹88.8 and 5.1% above VWAP, indicating strong near-term momentum. However, the stock lacks meaningful earnings visibility (EPS = ₹0.0), preventing P/E valuation; the P/B of 2.6 appears elevated for a healthcare provider without demonstrated profitability metrics. The combination of overbought technicals (RSI 75), low delivery % (13.3%), and absence of earnings history creates elevated valuation and execution risk despite strong promoter conviction (71.28% holding).
AI-generated analysis for informational purposes only — not SEBI-registered investment advice.
See Full AI Analysis — Free FREE →No recent news available for Hannah Joseph Hospital.
Hannah Joseph Hospital shares were last quoted at ₹101.85 (-1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Hannah Joseph Hospital has a price-to-earnings (P/E) ratio of 21.80 and a price-to-book (P/B) ratio of 2.50. The industry P/E is 99.89.
The 52-week high of Hannah Joseph Hospital is ₹128.80 and the 52-week low is ₹55.99.
The market capitalisation of Hannah Joseph Hospital is about ₹243.89 crore.
This page is for information and is not investment advice. As per the data shown here, Hannah Joseph Hospital has a 3-year ROE of 14.00%, 3-year profit growth of 121.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 71.28% of Hannah Joseph Hospital.
Hannah Joseph Hospital belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z